Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.

about

Screening, staging, and naming of presymptomatic type 1 diabetes.

P2860

Q48201273-20657535-5B48-4FB3-A9AC-3C313073F4B6

P2860

Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.

Item

http://www.wikidata.org/entity/Q40998700

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Antibodies to post-translation ...... f type 1 diabetes in children.

@en

type

Item

label

Antibodies to post-translation ...... f type 1 diabetes in children.

@en

prefLabel

Antibodies to post-translation ...... f type 1 diabetes in children.

@en

P1476

Antibodies to post-translation ...... f type 1 diabetes in children.

@en

P2093

Ahuva Nissim

http://www.w3.org/2001/XMLSchema#string

Chiara Vinci

http://www.w3.org/2001/XMLSchema#string

Nicola Napoli

http://www.w3.org/2001/XMLSchema#string

Paolo Pozzilli

http://www.w3.org/2001/XMLSchema#string

Rocky Strollo

http://www.w3.org/2001/XMLSchema#string

P2860

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

Reactive oxygen and nitrogen species generation, antioxidant defenses, and β-cell function: a critical role for amino acids

HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families

Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus

Prediction of type 1 diabetes in the general population.

Additional autoimmune disease found in 33% of patients at type 1 diabetes onset.

A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.

Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion

Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

P2888

s00125-017-4296-1

P304

1467-1474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00125-017-4296-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Johnny Ludvigsson

P577

2017-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28526919

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

biomarker

P932

5491589

http://www.w3.org/2001/XMLSchema#string

Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.

about

P2860

P2860

Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932